Web Analytics

3 Latest Announced Rounds

  • $5,300,000
    Seed

    4 Investors

    Software Development
    Oct 24th, 2025
  • $20,000,000
    Series A

    1 Investors

    Financial Services
    Oct 24th, 2025
  • $38,500,000
    Seed

    4 Investors

    Technology, Information and Internet
    Oct 24th, 2025
$822.16M Raised in 50 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Dispatch Bio

start up
  • 24/07/2025
  • Series A
  • Undisclosed Amount

Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.


Related People

Sabah ÖneyFounder

Sabah Öney United States - San Francisco Bay Area

N/A